|
|
News Breaks | | | | December 26, 2012 | | 13:17 EDT |  | MNKD | MannKind CEO buys 40M shares, holders approve increase in authorized shares
MannKind disclosed in a regulatory filing that at a special stockholders' meeting held on December 20, its stockholders approved an amendment to its Amended and Restated Certificate of Incorporation to increase the authorized shares of MannKind common stock from 350,000,000 shares to 550,000,000 shares. The company also stated that on December 21, following the approval of the amendment, the company completed the closing of its previously announced issuance and sale of 40,000,000 unregistered shares of its common stock and unregistered warrants to purchase an aggregate of 30,000,000 shares of its common stock to The Mann Group, an entity controlled by its chief executive officer and principal stockholder, Alfred Mann. The aggregate purchase price for the shares and warrants that were issued to The Mann Group was approximately $107.4M and was paid for by cancelling principal indebtedness owed to The Mann Group under the Amended and Restated Promissory Note issued by MannKind to The Mann Group on October 18. In afternoon trading, shares of MannKind rose 15c, or 6.81%, to $2.35. | |
|
News For MNKD From The Last 14 Days Check below for free stories on MNKD the last two weeks. |
|
|
| May 23, 2013 | | 11:24 EDT |  | MNKD | High option volume stocks: ZTS AMLP CTAS MNKD CYS
 Subscribe for More Information | | | 09:59 EDT |  | MNKD | MannKind bucks general market downdraft, but falls from early highs
The stock was up sharply to $6.82, a new 52-week high, but has since fallen to $6.33. At that price, next support is at $6.23, the prior day close, and then at $6.05. Resistance is now at $6.54, the prior day high. | | | 05:49 EDT | | MNKD | Stocks with implied volatility movement; MNKD ORCL
Stocks with implied volatility movement; MannKind (MNKD), Oracle (ORCL) according to IVolatility. | | | May 22, 2013 | | 16:00 EDT | | MNKD | Options Update; May 22, 2013
Subscribe for More Information | | | 11:50 EDT | | MNKD | High option volume stocks: ZTS AIRM GLDD GTXI MNKD
Subscribe for More Information | | | 11:46 EDT | | MNKD | MannKind volatility elevated on sharp rally to 28-month high
Subscribe for More Information | | | May 17, 2013 | | 10:25 EDT |  | MNKD | Summer Street says more optimistic on MannKind approval
Summer Street says it is more optimistic that the current trials of MannKind's inhalable insulin Afrezza could lead to FDA approval. The firm notes the product is completing two phase III trials and that it has been skeptical of approval in the past. Summer Street does not have an official rating on shares of MannKind, which are up 22c to $5.38 in early trading. | | | May 9, 2013 | | 16:02 EDT |  | MNKD | MannKind reports Q1 EPS (15c), consensus (15c)
Cash and cash equivalents were $28M at March 31. | |
|
|
|
|
|
|
